JP2023502576A5 - - Google Patents
Info
- Publication number
- JP2023502576A5 JP2023502576A5 JP2022524183A JP2022524183A JP2023502576A5 JP 2023502576 A5 JP2023502576 A5 JP 2023502576A5 JP 2022524183 A JP2022524183 A JP 2022524183A JP 2022524183 A JP2022524183 A JP 2022524183A JP 2023502576 A5 JP2023502576 A5 JP 2023502576A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- item
- disease
- ionizable
- itr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962939326P | 2019-11-22 | 2019-11-22 | |
| US62/939,326 | 2019-11-22 | ||
| US202063026493P | 2020-05-18 | 2020-05-18 | |
| US63/026,493 | 2020-05-18 | ||
| PCT/US2020/061801 WO2021102411A1 (en) | 2019-11-22 | 2020-11-23 | Ionizable lipids and nanoparticle compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023502576A JP2023502576A (ja) | 2023-01-25 |
| JP2023502576A5 true JP2023502576A5 (cg-RX-API-DMAC7.html) | 2023-12-01 |
Family
ID=73854943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022524183A Pending JP2023502576A (ja) | 2019-11-22 | 2020-11-23 | イオン化可能な脂質およびそれらのナノ粒子組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220370357A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4061797A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023502576A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102958677B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114787127B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020385378A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022007481A2 (cg-RX-API-DMAC7.html) |
| IL (2) | IL293039B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022006033A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021102411A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3864163T3 (da) | 2018-10-09 | 2024-05-06 | Univ British Columbia | Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed |
| US11613472B2 (en) * | 2019-07-22 | 2023-03-28 | King Fahd University Of Petroleum And Minerals | Dumbbell-shaped calcium hydroxide nanoparticles, an enhanced fuel comprising the nanoparticles, and a method for making |
| CN115968280A (zh) * | 2020-05-18 | 2023-04-14 | 世代生物公司 | 新型脂质及其纳米颗粒组合物 |
| AU2021307952A1 (en) * | 2020-07-17 | 2023-03-02 | Generation Bio Co. | Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof |
| MX2023001109A (es) | 2020-07-27 | 2023-04-24 | Anjarium Biosciences Ag | Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas. |
| CN117098541A (zh) | 2020-11-25 | 2023-11-21 | 阿卡格拉医药公司 | 用于递送核酸的脂质纳米粒及相关使用方法 |
| CA3215963A1 (en) * | 2021-05-28 | 2022-12-01 | Yaoxin LIN | Lipid compound and use thereof in delivery of nucleic acid |
| CN117642380A (zh) * | 2021-06-14 | 2024-03-01 | 世代生物公司 | 阳离子脂质及其组合物 |
| EP4124348A1 (en) * | 2021-07-30 | 2023-02-01 | 4basebio UK Ltd | Nanoparticles for cell delivery |
| WO2023015200A1 (en) * | 2021-08-04 | 2023-02-09 | The Trustees Of The University Of Pennsylvania | Amniotic fluid stabilized compositions and methods for in utero delivery of therapeutic agents |
| WO2023121964A1 (en) * | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterials comprising disulfides |
| EP4482819A2 (en) * | 2022-02-24 | 2025-01-01 | Vivasor, Inc. | Novel ionizable cationic lipids |
| WO2023183300A1 (en) * | 2022-03-22 | 2023-09-28 | The Children's Medical Center Corporation | Compositions and methods for prevention and treatment of genetic disease |
| WO2023230098A1 (en) | 2022-05-23 | 2023-11-30 | Logicbio Therapeutics, Inc. | Gene therapy compositions and methods of use thereof |
| WO2023230587A2 (en) | 2022-05-25 | 2023-11-30 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof |
| US20240150306A1 (en) * | 2022-09-27 | 2024-05-09 | Reinvigoron Theratech, Inc. | Compounds with cleavable disulfide moieties |
| WO2024081639A1 (en) * | 2022-10-11 | 2024-04-18 | Seawolf Therapeutics, Inc. | Novel lipid nanoparticle compositions for the delivery of nucleic acids |
| AU2023406321A1 (en) | 2022-12-01 | 2025-05-29 | Generation Bio Co. | Novel polyglycerol-conjugated lipids and lipid nanoparticle compositions comprising the same |
| WO2024140893A1 (zh) | 2022-12-29 | 2024-07-04 | 辽宁键凯科技有限公司 | 一种类固醇-阳离子脂质化合物及其应用 |
| US20260116844A1 (en) | 2022-12-29 | 2026-04-30 | SurgiNex Co., Ltd. | Lipid nanoparticle formulation comprising ionized lipids with branched structure, and use thereof |
| CN116444378A (zh) * | 2023-02-14 | 2023-07-18 | 广东优康精细化工有限公司 | 一种n-甲基异丙基胺的合成方法 |
| WO2024183497A1 (zh) * | 2023-03-09 | 2024-09-12 | 北京剂泰医药科技有限公司 | 一种鞘内递送制剂及其用途 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| JP2026524800A (ja) * | 2023-06-15 | 2026-07-24 | セリナ・セラピューティクス(エイ・エル)・インコーポレイテッド | ペンダント型カチオン基とのポリ(オキサゾリン)コンジュゲート並びにそれらを含む脂質ナノ粒子及びポリプレックス |
| US20260234104A1 (en) * | 2023-12-15 | 2026-08-13 | Xiamen Sinopeg Biotech Co., Ltd. | Degradable cationic lipid containing a disulfide bond and applications thereof |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026064512A1 (en) | 2024-09-18 | 2026-03-26 | Generation Bio Co. | Polyglycerol-conjugated lipids and lipid nanoparticle compositions comprising the same |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
| CA2289702C (en) | 1997-05-14 | 2008-02-19 | Inex Pharmaceuticals Corp. | High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| US6320017B1 (en) | 1997-12-23 | 2001-11-20 | Inex Pharmaceuticals Corp. | Polyamide oligomers |
| AU6814901A (en) | 2000-06-01 | 2001-12-11 | Univ North Carolina | Methods and compounds for controlled release of recombinant parvovirus vectors |
| WO2002087541A1 (en) | 2001-04-30 | 2002-11-07 | Protiva Biotherapeutics Inc. | Lipid-based formulations for gene transfer |
| EP1519714B1 (en) | 2002-06-28 | 2010-10-20 | Protiva Biotherapeutics Inc. | Method and apparatus for producing liposomes |
| CN1882693B (zh) | 2003-09-15 | 2012-08-15 | 普洛体维生物治疗公司 | 聚乙二醇修饰的脂质化合物及其应用 |
| US7404969B2 (en) | 2005-02-14 | 2008-07-29 | Sirna Therapeutics, Inc. | Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| JP5639338B2 (ja) | 2005-07-27 | 2014-12-10 | プロチバ バイオセラピューティクス インコーポレイティッド | リポソームの製造システムおよび製造方法 |
| WO2008103276A2 (en) | 2007-02-16 | 2008-08-28 | Merck & Co., Inc. | Compositions and methods for potentiated activity of biologicaly active molecules |
| EP3100718B1 (en) | 2008-01-02 | 2019-11-27 | Arbutus Biopharma Corporation | Improved compositions and methods for the delivery of nucleic acids |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| EP2310440A4 (en) | 2008-07-10 | 2013-06-05 | Serina Therapeutics Inc | POLYOXAZOLINES WITH INTERNAL END GROUPS, POLYOXAZOLINES MANUFACTURED FROM PROTECTED INITIAL GROUPS AND CORRESPONDING COMPOUNDS |
| US9018187B2 (en) * | 2009-07-01 | 2015-04-28 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| EP3391877A1 (en) | 2010-04-08 | 2018-10-24 | The Trustees of Princeton University | Preparation of lipid nanoparticles |
| WO2011139911A2 (en) | 2010-04-29 | 2011-11-10 | Isis Pharmaceuticals, Inc. | Lipid formulated single stranded rna |
| US9006417B2 (en) | 2010-06-30 | 2015-04-14 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| US20120225129A1 (en) | 2010-08-20 | 2012-09-06 | Cerulean Pharma Inc. | Conjugates, particles, compositions, and related methods |
| CA2853689C (en) | 2011-11-04 | 2020-06-30 | Nitto Denko Corporation | Method of producing lipid nanoparticles for drug delivery |
| WO2013073480A1 (ja) * | 2011-11-18 | 2013-05-23 | 日油株式会社 | 細胞内動態を改善したカチオン性脂質 |
| US10426737B2 (en) | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| CA2953341C (en) | 2014-06-25 | 2023-01-24 | Acuitas Therapeutics Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| HUE067372T2 (hu) * | 2015-06-29 | 2024-10-28 | Acuitas Therapeutics Inc | Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására |
| CN108368028B (zh) | 2015-10-28 | 2021-09-03 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| DK3386484T3 (da) | 2015-12-10 | 2022-07-04 | Modernatx Inc | Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler |
| US12678515B2 (en) | 2015-12-30 | 2026-07-14 | Acuitas Therapeutics, Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| WO2018237369A2 (en) * | 2017-06-23 | 2018-12-27 | Vical Incorporated | Lipid nanoparticle (lnp)-mediated delivery of a crispr-expressing plasmid dna for treating chronic hepatitis b virus infection |
| EP3679148A4 (en) * | 2017-09-08 | 2021-06-09 | Generation Bio Co. | LIPID NANOPARTICLE FORMULATIONS FROM NONVIRAL, CAPSID-FREE DNA VECTORS |
| CA3094057C (en) | 2018-03-27 | 2025-04-08 | Nof Corporation | CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS |
-
2020
- 2020-11-23 AU AU2020385378A patent/AU2020385378A1/en active Pending
- 2020-11-23 KR KR1020227018002A patent/KR102958677B1/ko active Active
- 2020-11-23 EP EP20825350.0A patent/EP4061797A1/en active Pending
- 2020-11-23 JP JP2022524183A patent/JP2023502576A/ja active Pending
- 2020-11-23 US US17/642,314 patent/US20220370357A1/en active Pending
- 2020-11-23 MX MX2022006033A patent/MX2022006033A/es unknown
- 2020-11-23 BR BR112022007481A patent/BR112022007481A2/pt unknown
- 2020-11-23 WO PCT/US2020/061801 patent/WO2021102411A1/en not_active Ceased
- 2020-11-23 CN CN202080079323.8A patent/CN114787127B/zh active Active
- 2020-11-23 IL IL293039A patent/IL293039B2/en unknown
-
2025
- 2025-10-13 IL IL323923A patent/IL323923A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518985A5 (cg-RX-API-DMAC7.html) | ||
| JP2022546597A5 (cg-RX-API-DMAC7.html) | ||
| JP2024517644A5 (cg-RX-API-DMAC7.html) | ||
| JP2023534043A5 (cg-RX-API-DMAC7.html) | ||
| US12252470B2 (en) | Lipids and nanoparticle compositions thereof | |
| JP2024522692A5 (cg-RX-API-DMAC7.html) | ||
| JP2023527747A5 (cg-RX-API-DMAC7.html) | ||
| KR20230052895A (ko) | 폴리뉴클레오타이드를 감소된 크기의 지질 나노입자로 캡슐화하는 방법 및 신규한 지질 나노입자 제형 | |
| US20240293574A1 (en) | Cationic lipids and compositions thereof | |
| US20240226325A1 (en) | Cationic lipids and compositions thereof | |
| JP2024520756A5 (cg-RX-API-DMAC7.html) | ||
| US20230181764A1 (en) | Novel lipids and nanoparticle compositions thereof | |
| RU2023129760A (ru) | Катионные липиды и их композиции | |
| RU2023135629A (ru) | Катионные липиды и их композиции |